Brookwood Investment Group LLC Corcept Therapeutics Inc Call Options Transaction History
Brookwood Investment Group LLC
- $582 Billion
- Q1 2025
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|---|---|---|---|---|
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
Others Institutions Holding CORT
# of Institutions
477Shares Held
84MCall Options Held
1.43MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.25 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$757 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$587 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$466 Million1.13% of portfolio
-
Parallel Advisors, LLC3.97MShares$301 Million5.04% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $8.12B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...